Browse 25466 Federal Health Grants below, sorted by the deadline to apply.
The United States Government agency or department offering the grant is also listed.
Select a specific Health grant to read the full description of the opportunity.
The full description contains the grant type, total award amount, eligible applicants, important dates, and official contact details.
If you wish to search for a specific keyword or view grants sorted by governmental agency, use the links on the menu bar.
Close Date | Grant Title | Agency |
January 7th, 2027 |
Population Approaches to Reducing Alcohol-related Cancer Risk (R01 Clinical Trial Optional) |
National Institutes of Health |
May 7th, 2026 |
Assay Development and Screening for Discovery of Validated Chemical Hits for Brain Disorders (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
September 7th, 2027 |
Bioengineering Partnerships with Industry (U01 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2027 |
Academic-Industrial Partnerships (AIP) to Translate and Validate In Vivo Imaging Systems (R01 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2026 |
Engineering Next-Generation Human Nervous System Microphysiological Systems (R01 Clinical Trials Not Allowed) |
National Institutes of Health |
January 7th, 2026 |
Engineering Next-Generation Human Nervous System Microphysiological Systems (R21 Clinical Trials Not Allowed) |
National Institutes of Health |
January 7th, 2028 |
Clinical Characterization of Cancer Therapy-induced Adverse Sequelae and Mechanism-based Interventional Strategies (R01 Clinical Trial Optional) |
National Institutes of Health |
September 7th, 2026 |
Assay development and screening for discovery of chemical probes, drugs or immunomodulators (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
January 7th, 2028 |
Research With Activities Related to Diversity (ReWARD) (R01 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2028 |
Natural History of Disorders Screenable in the Newborn Period (R01 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2026 |
In-Depth Phenotyping and Research Using IMPC-Generated Knockout Mouse Strains Exhibiting Embryonic or Perinatal Lethality or Subviability (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
September 7th, 2025 |
Advancing Research to Understand Congenital Malformations (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
May 7th, 2026 |
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional) |
National Institutes of Health |
September 7th, 2026 |
Research Projects to Enhance Applicability of Mammalian Models for Translational Research (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
January 6th, 2028 |
Stimulating Hematology Investigation: New Endeavors (SHINE) (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
January 7th, 2028 |
Integration of Imaging and Fluid-Based Tumor Monitoring in Cancer Therapy (R01 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2028 |
Molecular Imaging of Inflammation in Cancer (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
January 7th, 2026 |
NIA Multi-site Clinical Trial Implementation Grant (R01 Clinical Trial Required) |
National Institutes of Health |
November 12th, 2027 |
NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed) |
National Institutes of Health |
February 27th, 2025 |
Engaging Loved ones in Recovery Processes to Enhance Recovery Capital and Outcomes (R61/R33 Clinical Trial Optional) |
National Institutes of Health |
|
December 12th, 2024 |
Limited Competition: Continued Development of INCLUDE (Investigation of Co-occurring Conditions across the Lifespan to Understand Down syndromE) Project Data Coordinating Center (U2C Clinical Trial Not Allowed) |
National Institutes of Health |
September 28th, 2026 |
BRAIN Initiative: Clinical Studies to Advance Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UH3 Clinical Trial Optional) |
National Institutes of Health |
September 28th, 2026 |
BRAIN Initiative: Next-Generation Devices for Recording and Modulation in the Human Central Nervous System (UG3/UH3 Clinical Trial Optional) |
National Institutes of Health |
October 25th, 2027 |
Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional) |
National Institutes of Health |
October 25th, 2027 |
Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional) |
National Institutes of Health |
February 19th, 2025 |
Addressing Challenges in Detecting New Drugs: Instrumentation for Alternative Analytical Methods (R41/R42 - Clinical Trials Optional) |
National Institutes of Health |
February 19th, 2025 |
Addressing Challenges in Detecting New Drugs: Instrumentation for Alternative Analytical Methods (R43/R44 - Clinical Trials Optional) |
National Institutes of Health |
October 20th, 2027 |
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed) |
National Institutes of Health |
March 26th, 2025 |
Combating Antibiotic-Resistant Bacteria Interdisciplinary Units (CARBIRUs) (P01 Clinical Trial Not Allowed) |
National Institutes of Health |
July 1st, 2025 |
NCI Clinical and Translational Exploratory/Developmental Studies (R21 Clinical Trial Optional) |
National Institutes of Health |
October 16th, 2026 |
CCRP Initiative: NIH Countermeasures Against Chemical Threats (CounterACT) Basic Research on Chemical Threats that Affect the Nervous System (R01 Clinical Trial Not Allowed) |
National Institutes of Health |
October 17th, 2025 |
NINDS Sustainable Transformation of Institutional Research Rigor (STIRR) Program (RC2 - Clinical Trial Not Allowed) |
National Institutes of Health |
June 2nd, 2027 |
Enhancing Mechanistic Research on Precision Probiotic Therapies (R33 Clinical Trial Optional) |
National Institutes of Health |
June 2nd, 2027 |
Enhancing Mechanistic Research on Precision Probiotic Therapies (R61/R33 Clinical Trial Optional) |
National Institutes of Health |
January 7th, 2028 |
Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required) |
National Institutes of Health |
January 7th, 2028 |
Pilot Effectiveness Trials for Post-Acute Interventions and Services to Optimize Longer-term Outcomes (R01 Clinical Trial Required) |
National Institutes of Health |
October 23rd, 2025 |
Mechanistic links between diet, lipid metabolism, and tumor growth and progression (U01 Clinical Trial Not Allowed) |
National Institutes of Health |
January 7th, 2028 |
Dissemination and Implementation Research in Health (R21 Clinical Trial Optional) |
National Institutes of Health |
October 20th, 2025 |
Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R21 Clinical Trial Optional) |
National Institutes of Health |
October 20th, 2025 |
Bidirectional Influences Between Adolescent Social Media Use and Mental Health (R01 Clinical Trial Optional) |
National Institutes of Health |